Stock TRDA ENTRADA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Entrada Therapeutics, Inc.

Equities

TRDA

US29384C1080

Real-time Estimate Cboe BZX
Other stock markets
 02:11:44 2024-05-15 pm EDT 		5-day change 1st Jan Change
14.5 USD +2.22% Intraday chart for Entrada Therapeutics, Inc. +3.70% -3.45%
May. 07 Entrada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 13 Entrada Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Entrada Therapeutics Adds President Role to COO Nathan Dowden
MT
Entrada Therapeutics Adds President Role to COO Nathan Dowden
MT
Entrada Therapeutics Promotes Nathan J. Dowden to President
CI
Entrada Therapeutics, Inc. Announces Board Changes
CI
Entrada Therapeutics, Inc. Appoints Gina Chapman to its Board of Directors, Effective September 1, 2023
CI
Insider Sell: Entrada Therapeutics
MT
Insider Sell: Entrada Therapeutics
MT
Insider Sell: Entrada Therapeutics
MT
Entrada Therapeutics, Inc. Announces Board Changes
CI
Entrada Therapeutics, Inc. Appoints Dr. Bernhardt Zeiher to Its Board of Directors
CI
Insider Sell: Entrada Therapeutics
MT
Insider Sell: Entrada Therapeutics
MT
Insider Sell: Entrada Therapeutics
MT
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
CI
Insider Sell: Entrada Therapeutics
MT
Insider Buy: Entrada Therapeutics
MT
Insider Buy: Entrada Therapeutics
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRDA Stock
  4. News Entrada Therapeutics, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW